SCAP:NYE-Series Portfolios Trust (USD)

ETF | Small Growth |

Last Closing

USD 35.91

Change

+0.06 (+0.16)%

Market Cap

N/A

Volume

4.90K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Small Growth

Symbol Name Price(Change) Market Cap
VBK Vanguard Small-Cap Growth Inde..

-0.28 (-0.10%)

USD 18.06B
XSMO Invesco S&P SmallCap Momentum ..

+0.33 (+0.50%)

USD 0.99B
VIOG Vanguard S&P Small-Cap 600 Gro..

+0.23 (+0.19%)

USD 0.98B
JSML Janus Henderson Small Cap Grow..

+0.34 (+0.52%)

USD 0.24B
IWO iShares Russell 2000 Growth ET..

+0.58 (+0.20%)

N/A
PXSG Invesco S&P SmallCap Momentum ..

+0.33 (+0.50%)

N/A
RZG Invesco S&P SmallCap 600® Pur..

+0.12 (+0.23%)

N/A
SLYG SPDR® S&P 600 Small Cap Growt..

+0.23 (+0.25%)

N/A

ETFs Containing SCAP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 664.04% 94% A 100% F
Dividend Return 14.54% 94% A 97% N/A
Total Return 678.59% 94% A 100% F
Trailing 5 Years  
Capital Gain 6.75% 6% D- 48% F
Dividend Return 2.18% 17% F 6% D-
Total Return 8.93% 6% D- 36% F
Average Annual (5 Year Horizon)  
Capital Gain 94.02% N/A N/A 97% N/A
Dividend Return 94.11% N/A N/A 97% N/A
Total Return 0.09% N/A N/A 3% F
Risk Return Profile  
Volatility (Standard Deviation) 239.81% N/A N/A 3% F
Risk Adjusted Return 39.24% N/A N/A 56% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike